marijuana stocks news

First MCHI Licensee on Target to be Growing by August 1

ST PETERSBURG, FL / ACCESSWIRE / February 3, 2015 / INCC’s wholly owned subsidiary, Medical Cannabis Holdings, Inc. (“MCHI”) announced that it is on target for leasing personnel, equipment, security, accounting, financing and compliance to Eden’s Garden, LLC, the first of MCHI’s 10 identified recreational grow licensees. “We anticipate the LaVeda grow to be operational by August 1, 2015 and providing payments to MCHI by October 1, 2015,” said Drew Newsom, President of MCHI.

Navigating the Colorado real estate market for the cannabis business can be a treacherous endeavor, requiring property with 1) the correct zoning 2) friendly local government 3) a landlord willing to allow cannabis in his building 4) no mortgage on the property which may be called by a federally insured bank 5) enough property to grow your business from tier one (3,600 plants), to tier two (6.000 plants), to tier three (10,200 plants), accommodating three 10,000 square foot buildings. MCHI has crossed these significant hurdles and is on its way to create significant revenue.

With real estate secured, the next challenge was to acquire the technology necessary to achieve an ambitious growth and profit plan. MCHI has placed a purchase order of 400 state-of-the-art lights from FutureWorld, (FWDG). These smart LED lights surpass the market standard with features like two-way communications, health and power usage web reports, remote frequency adjustments, and powerful analytics that allow growers to build and save strand-specific profiles for optimizing repeat growth cycles. The lights will be expert-tested and ready for use prior to August 1, 2015.

Having placed this purchase order of $385,000, MCHI will now avail itself of its $3 million dollar credit facility from three private shareholders in non-convertible notes which bears an interest rates of 18%.

Last week’s land lease and LED purchase order will allow MCHI to put three licensees on the five acres and start growing and profiting with breakthrough technology. Additionally, MCHI has the first right of refusal to lease additional land from FutureWorld. “This will provide MCHI with all the real estate it needs to facilitate the next 10 licensee’s grows,” commented INCC’s CEO Antonio F. Uccello.

ABOUT FUTUREWORLD CORP.

FutureWorld (Other OTC: FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.

To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at https://www.futureworldcorp.com or visit us at our Facebook pagefacebook.com/futureworldenergy or on Twitter @futureworldinc.

Cameron Cox
VP FutureWorld (FWDG)
727-642-0099 C
727-474-1816 O EXT 103

About International Consolidated Companies, Inc. (INCC) [Medical Cannabis Holdings, Inc.]

International Consolidated Companies, Inc. (INCC) is a publicly traded company focused on acquiring and operating businesses and technologies that will help drive efficiencies in the medical marijuana market.

Forward-looking statements except for historical information are contained herein. This document contains forward-looking statements within the meaning of Section 21-E of the Securities Exchange Act of 1934. These statements involve known and unknown risks and uncertainties that may cause the company’s actual results or outcomes to be materially different from those anticipated and discussed herein.

Further, the company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the company’s control. Other important factors that the company believes might cause such differences are discussed in the risk factors detailed in the company’s annual reports on Form 10-K and its quarterly reports on Form 10-Q both as filed with the Securities and Exchange Commission, which include the company’s cash flow difficulties and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the company’s filings with the Securities and Exchange Commission.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer appears here.

Contact information:

Drew Newsom
(662) 219-3787
International Consolidated Companies, Inc. [Medical Cannabis Holdings, Inc.]


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published.

You May Also Like

Innovative Industrial Properties (IIPR) Declares Fourth Quarter 2019 Dividends

Common Stock Dividend Increased 28% from Prior Quarter and 186% from Q4…

Green Thumb Industries Inc. (GTBIF) Announces Partnership with Last Prisoner Project

Green Thumb Industries Announces Partnership with Last Prisoner Project; Releases Short Documentary,…

MOUNTAIN HIGH ACQUISITIONS CORP (MYHI) rolls out Pilot Program aimed at helping Licensed Cannabis Growers

Mountain High Acquisitions Corp. rolls out Pilot Program aimed at helping Licensed…

$CBIS Brings CS-TATI-1 to the FDA

Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development…